Concepedia

Alterations in the fecal microbiota in patients with advanced cystic fibrosis liver disease after 6 months of elexacaftor/tezacaftor/ivacaftor

Jennifer Duong, Christopher E. Pope, Hillary S. Hayden, Carson J. Miller, Stephen J. Salipante, Steven M. Rowe, George M. Solomon, David P. Nichols, Lucas R. Hoffman, Michael R. Narkewicz,

Journal of Cystic Fibrosis · 2024 · 12 citations · 35 references

DOIFull text

Open access

Concepts

References

35

Alterations of the human gut microbiome in liver cirrhosis

Nan Qin, Fengling Yang, Ang Li et al. · Nature · 2014 · 2.3K citations

, , +14

Metagenomic microbial community profiling using unique clade-specific marker genes

Nicola Segata, Levi Waldron, Annalisa Ballarini et al. · Nature Methods · 2012 · 1.9K citations · Full text

, , +14

Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis

Lukáš Bajer, Miloslav Kverka, Martin Kostovčík et al. · World Journal of Gastroenterology · 2017 · 380 citations · Full text

, , +14

Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis: A Clinical Trial

American Journal of Respiratory and Critical Care Medicine · 2021 · 380 citations · Full text

, , +12

Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome

Carla Colombo · Hepatology · 2002 · 315 citations

, , +16